David Moskowitz, Ph.D., M.S.

Dr. David Moskowitz is Principal at MPM BioImpact, where he is focused primarily on early stage investments and company creation activities. He is especially passionate about areas where emergent techniques and technologies are enabling advances in the biosciences.

Before joining MPM BioImpact, David spent seven years with 8VC, where he co-led the formation of its bio practice, investing broadly within the biotechnology ecosystem as well as in the technology sector. His efforts spanned company formation to late-stage growth, where he co-founded several companies, held key leadership roles and served on a number of Boards.

David received his Ph.D. in Biomedical Informatics and M.S. in Statistics from Stanford University. His research focused on the development of statistical and machine learning approaches for analyzing genomics data, and the characterization of epigenetic changes associated with aging in T cells. Previously, David was a Bioinformatic Analyst at Einstein College of Medicine, where he worked on the genetics of aging and human disease. He performed his undergraduate studies in Computational Biology at Brown University.